Matches in Wikidata for { <http://www.wikidata.org/entity/Q92858525> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q92858525 description "article scientifique publié en 2020" @default.
- Q92858525 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92858525 description "scientific article published on 22 January 2020" @default.
- Q92858525 description "wetenschappelijk artikel" @default.
- Q92858525 description "наукова стаття, опублікована 22 січня 2020" @default.
- Q92858525 name "A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors" @default.
- Q92858525 name "A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors" @default.
- Q92858525 type Item @default.
- Q92858525 label "A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors" @default.
- Q92858525 label "A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors" @default.
- Q92858525 prefLabel "A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors" @default.
- Q92858525 prefLabel "A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors" @default.
- Q92858525 P1433 Q92858525-8F885385-206D-4403-BC41-80FEB69EE29A @default.
- Q92858525 P1476 Q92858525-8132BE64-861D-49C4-9641-96AC8744B5C7 @default.
- Q92858525 P2093 Q92858525-05C3B834-16ED-467F-9F33-AA8B3C60D94E @default.
- Q92858525 P2093 Q92858525-27927C13-4F61-49C3-976C-AAB491BDB3C3 @default.
- Q92858525 P2093 Q92858525-3AB0B01B-D41A-41B3-805D-2EDBD17F5C19 @default.
- Q92858525 P2093 Q92858525-48C92E21-781F-4453-B5DD-226D5248F31B @default.
- Q92858525 P2093 Q92858525-59A1D6AE-B8E4-412C-99E8-DD491C91C723 @default.
- Q92858525 P2093 Q92858525-60C10598-F59E-4741-BD4E-ED47C387BF97 @default.
- Q92858525 P2093 Q92858525-611E1CD1-0F9A-49A6-B0E0-90A360B18F1F @default.
- Q92858525 P2093 Q92858525-61401313-9FC1-4C4B-B461-68D0E1917660 @default.
- Q92858525 P2093 Q92858525-76A7D84D-FAD1-4978-8D5F-FB78C4230E4A @default.
- Q92858525 P2093 Q92858525-7AC01D93-D943-44D3-8FAC-375DC93B31C1 @default.
- Q92858525 P2093 Q92858525-9012E9CC-9B10-4EA0-B839-8B865D49E4C8 @default.
- Q92858525 P2093 Q92858525-9CF1EBC1-6BA5-4AA1-87BD-BCA8698A53BA @default.
- Q92858525 P2093 Q92858525-AC7A2DE6-9D0A-4EEF-AD41-A6BCC589A135 @default.
- Q92858525 P2093 Q92858525-CE11A2CE-0FFD-4928-9BFA-1B41B748DC38 @default.
- Q92858525 P2093 Q92858525-E7418F81-566F-46B2-AF61-E1EE3E682A11 @default.
- Q92858525 P2093 Q92858525-EB29CF25-7326-41E5-8161-7DD5D5869FE7 @default.
- Q92858525 P31 Q92858525-17777B20-6360-4D36-99B9-7A205FC7EDAF @default.
- Q92858525 P356 Q92858525-E8532D8C-2EA1-43A3-95B3-F5900BD6A358 @default.
- Q92858525 P50 Q92858525-15366C7C-466B-48BC-9FC3-53B7AFE0CC80 @default.
- Q92858525 P50 Q92858525-34A7B796-4EF5-4355-8941-5C83EEE39CEF @default.
- Q92858525 P50 Q92858525-B152E1B4-398A-4FA9-BCF0-14C568C93457 @default.
- Q92858525 P50 Q92858525-D2BEB6D8-A307-4459-99E7-3CB6D7D7900B @default.
- Q92858525 P50 Q92858525-F28CF0E8-41FE-4D33-BB5E-74515DFDB518 @default.
- Q92858525 P50 Q92858525-FAEA5DD1-CF54-4FDE-94F8-F11A89D16FBA @default.
- Q92858525 P577 Q92858525-E0D4D4B3-6A8F-425F-B81A-E37A23A3F73A @default.
- Q92858525 P698 Q92858525-FE6011CF-8650-4030-B653-00B8C920561C @default.
- Q92858525 P921 Q92858525-057870DF-53D0-4BDC-8C23-7B2A01AA71E6 @default.
- Q92858525 P932 Q92858525-B2E7519C-F743-468D-AFB7-34CE8B9544FB @default.
- Q92858525 P356 1078-0432.CCR-19-3356 @default.
- Q92858525 P698 31969335 @default.
- Q92858525 P1433 Q332253 @default.
- Q92858525 P1476 "A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors" @default.
- Q92858525 P2093 "Annette Fontaine" @default.
- Q92858525 P2093 "Charles D Blanke" @default.
- Q92858525 P2093 "Christine McLeod" @default.
- Q92858525 P2093 "Christopher W Ryan" @default.
- Q92858525 P2093 "Donna E Hansel" @default.
- Q92858525 P2093 "Edward Mayerson" @default.
- Q92858525 P2093 "Helen X Chen" @default.
- Q92858525 P2093 "Jourdain Hayward" @default.
- Q92858525 P2093 "Manisha H Shah" @default.
- Q92858525 P2093 "Marc Matrana" @default.
- Q92858525 P2093 "Megan Othus" @default.
- Q92858525 P2093 "Melissa Plets" @default.
- Q92858525 P2093 "Sandip P Patel" @default.
- Q92858525 P2093 "Tareq Al Baghdadi" @default.
- Q92858525 P2093 "Young Kwang Chae" @default.
- Q92858525 P2093 "Zoran Gatalica" @default.
- Q92858525 P31 Q13442814 @default.
- Q92858525 P356 "10.1158/1078-0432.CCR-19-3356" @default.
- Q92858525 P50 Q56614941 @default.
- Q92858525 P50 Q56957929 @default.
- Q92858525 P50 Q62066745 @default.
- Q92858525 P50 Q90099897 @default.
- Q92858525 P50 Q90711528 @default.
- Q92858525 P50 Q90833371 @default.
- Q92858525 P577 "2020-01-22T00:00:00Z" @default.
- Q92858525 P698 "31969335" @default.
- Q92858525 P921 Q42824440 @default.
- Q92858525 P932 "7231627" @default.